Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Briakinumab is superior to methotrexate and etanercept in treating psoriasis

Oct. 27, 2010

HIV vaccine MV1-F4 induces robust immune response in monkeys

Oct. 26, 2010

Merck & Co. and Scynexis characterize new efumafungin antifungals

Oct. 26, 2010

Linifanib monotherapy is active in phase II NSCLC trial

Oct. 26, 2010

LNPEP gene SNP is associated with outcome of patients with septic shock

Oct. 26, 2010

New beta-lactamase inhibitor MK-7655 shows promise in preclinical and clinical studies

Oct. 26, 2010

Phase II/III data support teriflunomide monotherapy for relapsing MS

Oct. 25, 2010

Telatinib shows promise in patients with cancer of the stomach or gastroesophageal junction

Oct. 25, 2010

Firategrast suppresses onset of new lesions in relapsing-remitting MS

Oct. 25, 2010

OBA-19 offers neuroprotection in model of ischemic stroke

Oct. 25, 2010

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.